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repeated cross-sectional and 
longitudinal survey of People 
living with HIV in Australia
Jennifer Power*, Graham Brown, Anthony Lyons, Rachel Thorpe, Gary W. Dowsett and 
Jayne Lucke
The Australian Research Centre in Sex, Health and Society, La Trobe University, Melbourne, VIC, Australia
Introduction: More than 27,000 Australians currently live with HIV. Most of these people 
have access to quality clinical care and antiretroviral treatment (ART) and can expect 
good general health. However, HIV-related stigma is a problem and many people living 
with HIV experience poorer than average mental health. Issues of aging are also of 
increasing concern. This paper describes the methods and sample for the HIV Futures 8 
study, a national survey of people living with HIV in Australia that aimed to identify factors 
that support health and well-being among this population. HIV Futures 8 forms part of 
a series of cross-sectional surveys (The “HIV Futures” studies) that have been repeated 
periodically since 1997. In the most recent survey, participants were able to opt into a 
prospective longitudinal study.
Materials and equipment: HIV Futures 8 was open to people aged over 17 who were 
living with HIV. Data were collected in 2015/2016 using a self-complete survey that con-
tained approximately 250 items related to physical and mental health, use of ART, HIV 
exposure and testing, financial security, social connectedness, relationships, life satisfac-
tion, resilience, stigma, use of health and support services, and health literacy. To enable 
comparison of cross-sectional data over time, questionnaire items were consistent with 
those used in previous HIV Futures surveys. In HIV Futures 8, participants were invited to 
volunteer coded information that will allow longitudinal follow-up when participants com-
plete subsequent HIV Futures surveys. The survey was advertised through the networks 
of HIV organizations, on social media and through HIV clinics and services. HIV Futures 
8 was completed by 895 participants. This represents approximately 3.8% of the total 
number of people living with diagnosed HIV in Australia in 2014.
Expected impact of the study on public health: Findings from HIV Futures 8 will 
contribute important insights into the complexity of factors that support physical and 
mental well-being among people living with HIV. The findings will also assist HIV services 
to align with broader public health goals related to increasing ART use and improving 
quality of life among people living with HIV.
Keywords: HIV, living with HIV, quality of life, antiretroviral treatment, longitudinal design
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INtroDUctIoN
The first Australian case of HIV infection was diagnosed in 
1982. More than 30 years later, there are now more than 27,000 
Australians living with HIV (1). Approximately, 1,000 new cases 
are diagnosed in Australia each year. This figure increased slightly 
during the previous decade, from 953 new diagnoses in 2005 to 
1,064 in 2012 at which level it has remained relatively stable. 
There were 1,081 new HIV diagnoses in 2014 (1).
The HIV epidemic in Australia occurs predominantly among 
gay men and other men who have sex with men (GMSM). 
Estimates indicate that, in 2014, between 14–18% of Australian 
GMSM were living with HIV (1). In 2014, 70% of new HIV diag-
noses occurred through male-to-male sexual transmission (1). 
This figure has remained consistent over time (1, 2). Australia 
is recognized internationally for its early implementation of 
effective HIV harm minimization and prevention strategies, 
facilitated through a partnership involving affected communi-
ties, government, clinicians, and researchers (3). Compared with 
other Western countries, the Australian response has successfully 
minimized HIV cases among injecting drug users, sex workers, 
and heterosexual populations (3, 4).
However, there is evidence that the Australian epidemic is 
diversifying (5, 6). In the past 5 years, the rate of new HIV diag-
noses among Indigenous Australians has increased, with 16% of 
these attributable to injecting drug use, a much greater propor-
tion in this transmission category than among non-Indigenous 
people born in Australia (1). While the proportion of new HIV 
diagnoses attributable to heterosexual sex has remained consist-
ent nationally for the past decade (at between 18 and 23%) (1), 
this is not the case in all jurisdictions. In the state of Western 
Australia, up to 50% of new HIV diagnoses are attributable to 
heterosexual sex, with 70% of these cases having acquired HIV 
overseas, most commonly in South East Asia (7). Nationally, 
there has also been an increase in new HIV diagnoses among 
people born overseas. In 2014, 39% of new HIV diagnoses attrib-
utable to heterosexual sex were among people from high HIV 
prevalence countries, most commonly low income countries in 
Sub-Saharan Africa or South East Asia. Among GMSM, the pro-
portion of new diagnoses among men born in Asian countries 
increased from 6% in 2005 to 15% in 2014 (1). These chang-
ing patterns mean the Australian HIV epidemic is now more 
complex than in the past. Approaches to prevention, testing, and 
care need to accommodate this changing epidemiology, greater 
cultural diversity, and global patterns of migration and mobility.
In addition, the nature of HIV prevention is changing 
largely due to significant advances in biomedical approaches 
to prevention (8, 9). Highly active combination antiretroviral 
treatment (ART) became available in Australia in 1997 (10). 
This was a major advance in HIV treatment that significantly 
increased health and life expectancy for people living with HIV 
(11). Since 1997, HIV treatment regimens have become much 
simpler (in some cases just one pill per day) and have fewer 
side effects (11, 12). Increasingly, studies are pointing to the 
long term personal and public health benefits of initiating ART 
use soon after diagnosis (13, 14). Importantly, the majority of 
people living with HIV who are on ART are able to maintain 
viral suppression (15). Some studies have shown that the risk 
of onward HIV transmission from a person with full viral sup-
pression is close to zero (14, 16, 17). Given the effectiveness of 
ART at reducing onward HIV transmission, encouraging early 
and sustained use of ART among people living with HIV has 
become central to prevention strategies both in Australia and 
globally (often referred to as “treatment as prevention” or TasP) 
(18, 19).
In Australia, clinical guidelines regarding prescription of ART 
were changed in 2015 to facilitate this. Previous guidelines had 
indicated ART was only appropriate for people whose CD4 count 
was less than 500  U/ml3. Today, there are no such stipulations 
and early uptake is encouraged (20). International and Australian 
targets aim for 90% of people living with HIV to be on ART as 
part of a strategy to reduce, or even eliminate, new HIV transmis-
sions (18, 21). In 2014, it was estimated that 73% of Australians 
diagnosed with HIV were taking ART and, of these, 92% had 
achieved viral suppression (1). Some studies have found a slightly 
higher number are on ART (22). “Treatment as prevention” now 
sits alongside other interventions including condom use, promo-
tion of HIV testing, and provision of other pharmacological HIV 
prevention methods including pre- and post-exposure prophy-
laxis (PrEP and PEP), which are ART medications taken by HIV 
negative people before or after a potential exposure to HIV to 
prevent HIV infection (9, 23, 24).
The effectiveness of ART has also generated changes in the age 
profile of people living with HIV. It has been estimated that by 
2020, close to 45% of people living with HIV in Australia will be 
aged over 50 years (25). Aging in this population has an impact 
on health and care needs in both the HIV and mainstream health 
sectors. In particular, there is an increasing need for expertise in 
the management of health conditions associated with aging (such 
as heart disease, cancers, diabetes, and neurocognitive impair-
ments) alongside HIV treatment and care (26). The support and 
social needs of older people living with HIV may also differ from 
those of younger or newly diagnosed people, meaning the HIV 
community and support sectors increasingly have to accommo-
date diverse needs with respect to the age range of their clients 
and members (27).
Broader cultural and technological changes have influenced 
the HIV sector and the ways in which people living with HIV 
seek information and social connection. The online environ-
ment now plays an important role in the HIV response as 
a site of education and information provision (28, 29). It is 
also a space where people seek out others living with HIV 
for social connection or support (30) and, increasingly, it is 
a place where people meet prospective sexual and romantic 
partners (31, 32). HIV prevention and disclosure of HIV status 
is managed in unique and evolving ways in online forums, 
particularly among GMSM.
As a consequence of the changing nature of the HIV epidemic, 
and of HIV prevention and care, the story of well-being among 
people living with HIV is shifting and dynamic. Research in this 
area is still highly relevant, even at a time when HIV treatment 
is so effective that an HIV diagnosis does not necessarily mean 
lower life expectancy, poorer health, or poorer quality of life—at 
least for someone living in a high-income country (33).
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However, there are issues that have seen less change over 
time. Stigma and discrimination associated with HIV are still 
prevalent (34) and have a negative impact on the lives of many 
people living with HIV (35, 36). There are ongoing challenges 
for people living with HIV in the negotiation of intimate rela-
tionships, and in relation to disclosure of HIV status to friends, 
family, and colleagues as well as health-care providers (34, 
37). The introduction of TasP and PrEP may also influence the 
manifestation of stigma. For example, TasP has the capacity to 
reduce the stigma associated with fear of transmission while 
simultaneously increasing stigma for those not taking treatment 
or with detectable viral loads (38). Stigma can affect mental 
health and well-being at the individual level (35, 39). It can also 
interrupt and undermine campaigns to increase testing for HIV 
and other prevention initiatives (40). Stigma is a difficult con-
cept to operationalize or monitor in research as it may manifest 
in various ways, for example, as outright acts of discrimination, 
or as a low-level and ongoing anxiety carried by people living 
with HIV. Often stigma is associated with fear of the possibility 
of being rejected by, or alienated from, others (37). Stigma also 
operates at a structural level, implicitly influencing decisions 
relating to health-care funding, policy direction, or even the 
criminalization of HIV transmission (40). At all these levels, 
stigma is a major issue in the lives of people living with HIV 
that warrants attention in the Australian and international HIV 
response (34).
this study
This paper describes the method and sample of the HIV Futures 
8 study. HIV Futures 8 is a cross-sectional survey of adults liv-
ing with HIV in Australia. The survey forms part of a series 
of cross-sectional surveys of this population that have been 
repeated periodically (every 2–3 years) since 1997. HIV Futures 
8 is the eighth iteration of this survey. In each survey, data have 
been collected on issues described above, including aging, 
stigma, physical and emotional well-being, and ART uptake. 
When the HIV Futures study was established in 1997, highly 
active combination ART had only been available in Australia 
for 12 months. This meant that, while ill-health and HIV treat-
ment remained a major issue of concern for many people living 
with HIV, other life issues were emerging (or re-emerging) as 
important—relationships, identity, employment, and housing. 
Indeed, many people living with HIV were considering return-
ing to work as their health improved with the new treatments. 
For some people, longer life expectancy required reconsid-
eration of their financial situation (41). As such, the 1997 HIV 
Futures study was designed to identify and explore needs of 
people living with HIV in the new era of ART. The study was 
aimed to be “an investigation of the various ramifications of the 
changed perception and experience of HIV on the ways that 
people living with HIV/AIDS lead their lives” (41) (p. 8).
Between July 2015 and June 2016, data were collected for the 
eighth iteration of the HIV Futures study—HIV Futures 8. To 
ensure the survey adequately captured the complexities of the 
current environment with respect to HIV, the survey instrument 
for HIV Futures 8 was significantly revised from previous ver-
sions. This was done through extensive consultation with people 
living with HIV, HIV community organizations, clinicians, gov-
ernment, and others working in the Australian HIV sector. 
The updated instrument was designed to capture information 
relevant to the contemporary situation, while also allowing for 
comparisons over time with previous versions of HIV Futures. 
In HIV Futures 8, participants were also invited to opt into a 
prospective longitudinal study of their health and well-being over 
time by providing coded information that will enable researchers 
to match their responses to future HIV Futures surveys.
The aims of the HIV Futures 8 survey were to:
•	 describe the social and demographic characteristics of people 
diagnosed with HIV in Australia
•	 provide a measure of well-being among people living with HIV 
in Australia that is comparable with previous HIV Futures 
datasets
•	 identify factors that support health and well-being among 
people living with HIV in Australia
•	 provide data on ART use, and non-use, as well as clinical and 
community service use among people living with HIV in 
Australia.
This paper describes the design, instrument, sampling, recruit-
ment, and data collection methods used for HIV Futures 8 and 
provides an overview of the sample characteristics.
MAtErIAls AND EQUIPMENt
survey Instrument/Measures
HIV Futures 8 is a broad, omnibus survey. The survey instrument 
contained approximately 250 items as detailed below.
Demographic Characteristics
Standard items were used to measure age, sex/gender, place of 
residence (postcode), religion, highest education level, total 
household income, current employment, current relationship 
status, gender and sexuality of partners over lifetime, Australian 
residency, and visa status.
Financial and Housing Security
Standard items were used to ask participants about their current 
housing arrangements, including the people with whom they live 
and type of housing (rental, owned, public, others). One item 
asked participants if they had experienced difficulty managing 
the cost of basic items for living (utility payments, rent, food, and 
so forth) in the past 12 months. This was a modified version of 
an item used in the Australian Household Income and Labour 
Dynamics Australia (HILDA) survey, a national population-
based survey of Australian households. Two other items from the 
HILDA survey were also included: capacity to raise $3,000 in a 
short period of time and source of this revenue (42, 43).
HIV Exposure and Testing
Participants were asked: which year they tested positive for HIV; 
the year they believe they acquired HIV; the means by which they 
acquired HIV (sex with a man, sex with a woman, injecting drug 
use, blood products, other); the location in which they acquired 
HIV (Australia/overseas). Participants were also asked the results 
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of their most recent CD4 count and viral load testing. These items 
all align with previous HIV Futures questionnaires, allowing 
comparison between each survey from 1997 onward. In HIV 
Futures 8, items were also added about whether participants had 
ever used PEP or PrEP medication prior to testing positive for 
HIV and whether they used contract tracing/partner notification 
services after diagnosis.
ART Use and Adherence
Participants were asked whether they currently use ART and 
which ART medications they currently use. Respondents not 
currently using ART were asked whether they had used ART in 
the past and to indicate their reasons for not taking ART.
To measure attitudes toward ART use, participants were asked 
to respond to six statements relating to beliefs and attitudes about 
beginning ART and its safety and effectiveness. Responses were 
recorded on a 4-point Likert scale, “strongly disagree” to “strongly 
agree.” These questions were all comparable to previous versions 
of HIV Futures.
One item asked participants to indicate what percentage of 
time they adhered to their ART regimen in the past month (44). 
A further item asked participants to identify the main reasons 
why they missed doses of ART in the previous month, and 
this is comparable to the AIDS clinical trial group adherence 
baseline questionnaire (45). Several items asked participants 
to report on any problems they have with ART use including 
experience of side-effects, whether they had recently changed 
treatment combination, the reason for this change, difficul-
ties accessing prescriptions, and cost of filling prescriptions. 
These questions were all comparable to previous versions of 
HIV  Futures.
Health-Related Quality of Life
Several items together can be used to build a concept of overall 
health-related quality of life including general physical and 
mental well-being, life satisfaction, social connectedness, and 
resilience. These measures are all listed below.
Physical and Mental Health
The survey included the RAND Short Form 36 1.0 (SF 36) (46) 
that has been validated for use with people living with HIV 
(47). This is a widely used measure of health-related quality 
of life that incorporates physical and mental health as well as 
functional and role impairment. Functional impairment is also 
measured using one item, “Do you regularly need help with 
daily tasks because of long-term illness or disability?” which 
is derived from the Australian Longitudinal Study of Women’s 
Health (48).
Participants were also asked whether they had ever been 
diagnosed with a mental health condition or a range of other 
physical health conditions, including hepatitis B or C. One item 
asked participants to identify any sexually transmissible infec-
tion they had been diagnosed with in the past 12 months. One 
item asked participants if they had been affected by symptoms 
of advanced HIV disease (AIDS-related illnesses) in the past 
12  months. A further general item asked participants to rate 
their overall sense of well-being using a 4-point Likert scale. 
This general item was also included in previous HIV Futures 
surveys.
Satisfaction with Life
One item with several sub-questions asked participants to 
indicate their satisfaction with life in a range of areas including 
employment, housing, safety, community, health, neighborhood, 
and leisure time. This was followed by a global measure of overall 
sense of life satisfaction. Both items used a 0–10 scale, with 0 
indicating completely dissatisfied and 10 indicating completely 
satisfied. These items were also designed to be comparable with 
the HILDA survey (49).
Resilience
HIV Futures 8 included the 10-item version of the Connor-
Davidson resilience scale (50), in which participants were asked to 
respond to a series of statements relating to resilience and coping. 
Participants scored each item on a 5-point Likert scale, ranging 
from 0 (not true at all) to 4 (true nearly all the time). Scores were 
summed to a maximum of 40. A higher score indicates higher 
resilience (51).
Social Connectedness and Support, Including with 
Other People Living with HIV
General sense of connectedness to others was measured using 
10 items in which participants were asked to signal the extent to 
which they agree with 10 statements relating to friendship and 
support. Scores were recorded on a 7-point Likert scale. These 
items were derived from the HILDA survey (52). Following 
Baker (52), scores were calculated so that they ranged from 
−30 to 30 with a score closer to −30 indicating that the person 
perceives they have very little support or friendship available 
to them.
Participants were asked to indicate whether they person-
ally know any other people who are HIV positive, how much 
of their free time is spent with other HIV positive people 
and whether they have contact with HIV-related organiza-
tions. These items were consistent with previous HIV Futures 
questionnaires.
A series of questions were also included that related to sense 
of connectedness to the lesbian, gay, bisexual, and transgender 
(LGBT) community. These were adapted from Frost and Meyer’s 
LGBT community connectedness scale (53). These questions 
were only asked of men who identified as gay or bisexual.
Stigma and Discrimination
The instrument included the Berger HIV Stigma Scale (54), a 
40-item scale that measures different constructs related to HIV 
stigma to produce four subscales: (1) personalized stigma, which 
relates to the impact of others knowing about the participant’s 
HIV status, including loss of friends or avoidance of others; 
(2) disclosure concerns, which measures difficulties related to 
disclosure or hiding HIV status from others; (3) negative self-
image, which measures shame, guilt, and negative self-worth 
associated with HIV status; and (4) public attitudes, which 
measures participants’ perceptions of what others think about 
people living with HIV. Participants responded to each item 
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using a 4-point Likert scale. Responses were scored from 1 
to 4 giving total possible scores of 40–160, with higher scores 
indicating greater stigma.
Use of Health Care Services
Participants were asked whether they have a Medicare card 
(Australian national health insurance, which is not available to 
non-residents) and whether they have private health insurance. 
Participants were also asked: which health-care professional/s 
they see for general and HIV-specific care and treatment; 
frequency of medical visits; use of home-based medical care; 
frequency of medical visits, costs associated with medical care; 
and distance traveled to access HIV specialist care. These ques-
tions were all comparable to previous HIV Futures surveys.
Health Literacy
The questionnaire included 12 items comprising three subscales 
that measured: feeling understood and supported by health-care 
providers; ability to engage actively with health-care providers; 
capacity to navigate the health-care system. These subscales 
were part of the Ophelia Understanding Health and Health-care 
Questionnaire (55).
Alcohol and Other Drug Use
The questionnaire included two items measuring use and 
frequency of tobacco smoking. The items were derived from 
the national Drug Strategy Household survey, 2013 (56). Three 
items that comprise the AUDIT-C questionnaire were included 
to measure frequency and quantity of alcohol consumption (57).
Frequency and impact of other drug use was measured using 
the following items: frequency of non-prescribed drug use in the 
past 12 months; the extent to which non-prescription drug use 
interferes with daily life; whether participants had been diagnosed 
with a substance misuse disorder in the past 12 months; and, if 
yes, whether treatment had been received for this. Questions 
relating to use of non-prescription drugs were consistent with 
previous HIV Futures surveys.
Relationships and Safe Sex
Participants were asked whether they had a current romantic 
partner or partners, the HIV status of those partners, satisfac-
tion with their sexual and emotional relationships with their 
partners, and use of safe-sex methods within their current 
relationships, including condoms and their partner’s use of 
pre- or post-exposure prophylaxis. These questions were all 
comparable to previous HIV Futures surveys. Participants were 
also asked about sexual partners over the past 6 months includ-
ing regular and casual partners. With respect to participants’ 
most recent sexual encounters with casual partners (where 
applicable), participants were asked whether they were aware 
of their partners’ HIV status and their own disclosure of HIV 
status and safe-sex practices on those occasions. For GMSM, 
questions about casual sexual relationships in the past 6 months 
were designed to be comparable with the Gay Community 
Periodic Survey, a survey of gay and other homosexually active 
men (both HIV positive and negative) conducted in Australia 
every 2  years (58).
Criminalization
There were six items that asked direct questions about the extent 
to which participants were aware of Australian laws regarding 
requirements for disclosure of their HIV status to sexual partners 
and the impact of such laws on their decision-making regarding 
disclosure and condom use.
Attitudes toward Participation in Research toward a 
Cure for HIV
A series of items were included to explore the attitudes of 
Australians living with HIV toward recent clinical research 
aimed toward developing a cure for HIV. Participants were asked 
to rank, from 1 to 6, the possible benefits of a HIV cure. The 
options included social benefits, such as not being considered a 
person with HIV, and medical benefits such as no longer being 
able to transmit HIV to others. These scenarios were adapted, 
with permission, from a previous Australian survey of clinical 
trial patients run by McMahon and colleagues (59) who had 
derived them originally from the European community survey 
on HIV cure (60). To identify characteristics of participants who 
would be willing to participate in a trial, the survey instrument 
included one primary outcome measure: If you had the opportu-
nity to participate in an HIV cure-related clinical trial beginning 
tomorrow, how willing would you be to participate? Responses 
were recorded on a four-point Likert scale (1: not at all willing to; 
4: very willing). Where participants indicted they were willing to 
participate in a HIV cure trial, a series of questions was asked of 
them relating to possible social and personal benefits. These ques-
tions were adapted, with permission, from Arnold and colleagues’ 
US-based survey of people living with HIV (61).
stEPWIsE ProcEDUrEs
cross-sectional study Design  
and sample size
HIV Futures 8 is a cross-sectional survey of people living with 
HIV in Australia, which forms part of a series of repeated cross-
sectional surveys of this population that began in 1997. Data were 
collected between July 2015 and June 2016 using a self-complete 
instrument that could be filled in online or using a hardcopy 
booklet that was supplied to prospective participants with a reply 
paid envelope. The survey instrument contained approximately 
250 items as described above.
Since 1997, HIV Futures surveys have consistently achieved 
sample sizes of between 850 and 1,200 participants (22, 62–65). 
A similar sample size was the target for HIV Futures 8. This 
sample size has proven necessary in analysis of previous HIV 
surveys to ensure that subgroups, particularly those based on 
age and gender, are large enough to ensure appropriate reliability 
(66, 67).
longitudinal Design and sample size
In HIV Futures 8, participants were invited to provide informa-
tion to generate a unique participant code. This code enabled 
their responses to HIV Futures 8 to be paired with their responses 
to future versions of the survey—data collection for HIV Futures 
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9 is due to commence in 2018. Information used to generate the 
participant code included month and year of birth, first letter of 
first name, first letter of middle name (if applicable), and first 
letter of surname. The code therefore allows pairing between 
surveys to establish longitudinal data while also ensuring par-
ticipants remained anonymous. Participants were not asked to 
supply contact details within the questionnaire; however, those 
who completed the questionnaire online were able to open a 
separate online form in which they could leave their contact 
details to receive information about subsequent HIV Futures 
surveys. Participants who completed a hardcopy version of the 
questionnaire could email their contact details for inclusion on 
the contact database. All people on the contact database will be 
informed about HIV Futures 9 in 2018 and any future surveys.
Preliminary analysis of HIV Futures 8 data indicates that over 
750 participants provided information to generate a unique par-
ticipant code to enable longitudinal follow-up of their responses. 
We are aiming for a sample of 350 of these people in HIV Futures 
9 in 2018. This sample size is large enough to allow for robust 
statistical analysis and sub-group analysis, but is based on an 
assessment, determined by previous comparable research con-
ducted by members of the research team (67), that approximately 
50% attrition is likely.
recruitment
HIV Futures 8 was open to people living with HIV, aged over 
17 years and currently living in Australia. Given there is no avail-
able sampling frame, this study relied on a self-select sample. 
Participants were recruited through electronic advertising in a 
range of forums including advertisements sent through the email 
lists of HIV community organizations; advertising on relevant 
websites; social media advertising, particularly Facebook adver-
tisements targeting GMSM as well as general Facebook users who 
had interactions with HIV-related events such as World AIDS 
Day; advertisements on “dating apps” used by GMSM; and flyers 
and posters displayed in HIV clinics. Social media strategies also 
included peer leaders promoting the survey to their networks 
through established private “Facebook” groups for people living 
with HIV. These networks were also used to provide regular 
updates on recruitment progress to the online community. Hard 
copies of the survey were distributed through the mailing lists of 
HIV community organizations and made available in the waiting 
rooms of HIV clinics and community services.
Data Analysis
Data analysis will involve descriptive analysis of items related to 
ART use, ART adherence, physical and mental health, alcohol 
and other drug use, relationship status and safe-sex practices, 
and use of clinical and support services. Logistic and hierarchi-
cal regression modeling will be used to identify predictors of 
well-being. Outcome measures in these analyses will include 
physical and mental health, resilience, social connectedness, 
and perceptions of stigma. Analyses will also be run to iden-
tify predictors of well-being in specific subgroups including 
women, people aged over 50, people aged under 35, and people 
diagnosed with HIV in the previous 5 years. Where population 
data are available for particular measures, such as the SF 36, 
comparisons will be made with published findings. Data from 
HIV Futures 8 will be compared with previous HIV Futures 
datasets to track changes over time in: self-reported health and 
well-being, treatment use, attitudes toward treatment use, and 
feelings about disclosure of HIV status. Changes over time will 
be measured using basic statistical techniques (t-tests, analysis 
of variance test, and/or chi-square tests) to examine differences 
between each consecutive year or between an identified baseline 
year and other years. The baseline may be the first iteration 
of HIV Futures in 1997, or another iteration of the survey as 
relevant (for example, it may be more relevant just to examine 
changes over the past 10 years). A series of short topic-specific 
broadsheet reports will be generated and distributed to stake-
holders and community as they become available to ensure 
rapid distribution of results and to sustain engagement in the 
study over time. For this paper, data were analyzed descriptively 
to describe socio-demographic characteristics of the sample.
Ethics
Ethics approval for this study was granted by the La Trobe 
University College of Science, Health and Engineering Human 
Ethics Committee (SHE CHESC S15-100) as well as two 
community-based ethics committees: ACON (formerly the AIDS 
Council of NSW) and the Victorian AIDS Council. The key ethi-
cal concerns with this study relate to the importance of protecting 
confidentiality of participants through secure data storage and 
avoiding publication of any potentially identifiable information. 
Information about HIV and counseling services and support 
options were made available to all participants who completed 
the study.
ANtIcIPAtED rEsUlts
Over the past 20 years, HIV has shifted from being considered an 
untreatable, potentially fatal illness to a manageable chronic con-
dition in Australia where people generally have ready access to 
ART. The HIV Futures studies chart the impact of this change on 
issues related to everyday living with HIV, such as financial secu-
rity, employment, social and intimate relationships, stigma and 
discrimination, general well-being, and, increasingly, aging. HIV 
Futures 8 will build on the existing dataset, while also exploring 
issues related to the contemporary experience of living with HIV. 
In particular, these data will provide information about attitudes 
toward ART use among people living with HIV at a time when 
the policy and clinical focus on treatment as prevention has been 
rapidly evolving. HIV Futures 8 will also yield important findings 
on the experience of aging with HIV. Since 1997, the average age 
of HIV Futures participants has increased significantly. In HIV 
Futures 8, we anticipate there will be capacity—due to a larger 
number of participants aged over 50—to explore the impact of 
aging on the management of comorbidities, social connected-
ness, and financial security.
Participants
HIV Futures 8 was completed by 895 people living with HIV in 
Australia. This represents approximately 3.8% of the number of 
people living with diagnosed HIV in Australia in 2014 (1).
tAblE 1 | characteristics of participants.
N (%)
total n = 895
Age [mean (range)] 51 years  
(range 19–86 years)
Gender
Men 804 (90.5)
Women 74 (8.3)
Transgender 6 (<1)
Other or non-specified gender (excludes missing = 7) 4 (<1)
sexuality
Gay men 697 (78.7)
N (%)
total n = 895
Bisexual men 50 (5.6)
Heterosexual men 38 (4.3)
Lesbian/bisexual women 6 (<1)
Heterosexual women 65 (7.3)
Other (excludes missing = 10) 29 (3.2)
Aboriginal or torres strait Islander 21 (2.3)
country of birth
Australia 649 (72.5)
UK 68 (7.6)
New Zealand 42 (4.7)
European countries 36 (4.0)
Asian countries 29 (3.2)
African countries 17 (1.9)
USA and Canada 11 (1)
South America 9 (<1)
Middle east 5 (<1)
Pacific 3 (<1)
Unspecified 26 (2.9)
language
English spoken at home 854 (97.7)
English is first language 792 (88.5)
residency
Australian citizen or permanent resident 842 (97.6)
Work status
Working full time 341 (38.6)
Working part time 134 (15.2)
Home duties/unemployed not seeking work 64 (7.2)
Unemployed and seeking work 52 (5.9)
Retired/not working 160 (18.1)
Student 38 (4.3)
Disability support 47 (5.3)
Other (casual work, volunteer, carer) (excludes 
missing = 11)
48 (5.4)
Household income (Australian dollars)
$0–$49,999 377 (42.6)
$50,000–$99,999 258 (29.2)
$100,000–$149,999 102 (11.5)
$150,000+ 89 (10.1)
Don’t know or prefer not to say (excludes missing = 11) 58 (6.6)
Highest level of education
Less than year 12 (high school certificate) 130 (14.7)
Year 12 certificate 94 (10.6)
Tertiary diploma or trade certificate 265 (29.9)
University degree (excludes missing = 8) 398 (44.8)
Place of residence
Inner city/inner suburban 532 (60.7)
Outer suburban 109 (12.4)
Regional center (population 5,000+) 151 (17.2)
Rural (excludes missing = 18) 85 (9.7)
relationship status
Cohabiting with partner/spouse 276 (30.9)
Single (not in a relationship) 504 (56.3)
In a regular relationship with one or more partners 332 (37.1)
Other or unspecified 59 (6.6)
children
Have children (total) 177 (19.8)
Have children (men) 125 (15.5% of men)
Have children (women) 48 (64.8% of women)
Have children (trans or non-specified gender) 3 (30% of trans/ns 
gender) 
Currently living with dependent children 30 (3.4)
Number of years since HIV diagnosis [mean (range)] 15.2 years  
(range 1–35 years)
tAblE 1 | continued
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The majority of respondents completed the survey on-line 
(65%, n =  582), while 35% (n =  316) completed a hard copy 
of the survey. There were 338 participants (38%) who indicated 
they had participated in a previous HIV Futures study, while 
363 (41%) indicated HIV Futures 8 was the first HIV Futures 
survey they had completed (the remainder of participants were 
unsure if they had completed a previous survey or they did 
not respond to the question). To gauge effectiveness of recruit-
ment techniques, participants were asked where they found out 
about the study. The most common response was an email or 
(hardcopy) mail out from an HIV organization (n = 283, 32%), 
followed by an email that was sent to people who were on 
a contact list from previous HIV Futures surveys (n =  202, 
23%). Social media advertising also proved successful with 127 
(14%) seeing a “Facebook” advertisement, 53 (6%) seeing a 
post to a Facebook group for people living with HIV, and 37 
(4%) seeing an advertisement on a phone “app”. There were 127 
(14%) who picked up a hardcopy of the survey from a clinic 
or HIV organization.
The socio-demographic characteristics of the sample are 
shown in Table 1. These characteristics broadly reflect the pat-
tern of the HIV epidemic in Australia with respect to gender 
and sexuality (1). The majority of participants were men (91%, 
n =  804), over 80% (n =  747), identified as gay or bisexual 
men, and the most common mode through which participants 
acquired HIV was male-to-male sex (see Table 2). The average 
age of participants was 51 years and over half the sample (54.2%, 
n = 485) were aged 50 years or older. There has been a steady 
increase in the average age of participants since the first HIV 
Futures survey in 1997, when the average age was 39 years (41). 
In 2012 (HIV Futures 7), the average age was 49 years (22).
This was a well-educated sample, with 45% holding a univer-
sity degree. However, over 40% had a household income of less 
than AUD$50,000 per annum, well below the average Australian 
household income in 2014 (70). The majority of the sample was 
born in Australia (n =  649, 73%) and spoke English as their 
first language (n = 792, 89%). This is likely to reflect an under 
representation of people from non-English-speaking migrant 
communities, which will be discussed with respect to study 
limitations below.
We have compared key demographic characteristics of 
the HIV Futures 8 sample with published reports of sample 
(Continued )
tAblE 2 | comparison of HIV Futures 8 sample with Annual surveillance 
report 2015 and the AHoD Annual report 2016.
HIV Futures 
8 (%)a
surveillance 
report (%)b
AHoD 
(%)c
Gender
Men 91 91 92
Women 8 Not reported 
separately
8
Transgender <1 Not reported 
separately
0
Aboriginal or torres strait Islander 2.3 1.8 2
Exposure category
Male-to-male sex 80 67 72
Male homosexual contact and Injecting 
drug user (IDU)
<1 4 3
IDU 2 3 2
Heterosexual sex 7 13 17
Receipt of blood/blood products <1 1 1
Other 4 13 2
Missing 6 – 2
born outside Australia 28 40 18
taking Art 97 73 97
aPercentages exclude missing data, N = 895.
bGender and exposure categories include all new HIV diagnoses in Australia up to 2014 
(N = 35,122), estimates of Aboriginal and Torres Strait Islander people and people born 
outside Australia based on estimates of people living with HIV in 2014 (N = 27,150).
cCharacteristics based on all patients enrolled in Australian HIV Observational 
Database (AHOD), N = 4,270, percentage of people currently taking antiretroviral 
treatment (ART) based on patients under active follow-up in 2015, N = 2,408 
[Source: Ref. (1, 68, 69)].
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characteristics from two other Australian datasets: The Australian 
HIV Observational Database (AHOD) Annual Report 2016, and 
the HIV, Viral Hepatitis and Sexually Transmissible Infections 
in Australia Annual Surveillance Report 2015 (henceforth 
referred to as the Annual Surveillance Report) (see Table  2). 
AHOD is a prospective cohort study of HIV infected individuals 
attending specialized general medical practitioner sites, sexual 
health clinics, and tertiary referral centers throughout Australia 
(68). The study began in 1999 and currently has 4,270 patients 
enrolled, with 2,408 under active follow-up in 2015 (69). The 
Annual Surveillance Report incorporates information from 
multiple sources including the National HIV Registry, which 
is a record of each new HIV diagnoses in Australia, and the 
Australian Pharmaceutical Benefits Scheme, which records 
information on prescriptions obtained for ART (1). Table  2 
shows key characteristics of the sample for each dataset. In all 
three samples, over 90% of participants were men. HIV Futures 
8 had a slightly higher percentage of participants who had 
acquired HIV via male-to-male sex (80% compared with 67% 
for the Annual Surveillance Report and 72% for AHOD). This 
may be because there is a strong connection between Australian 
LGBT communities and the HIV community organizations that 
assisted in promoting HIV Futures 8. Consequently, gay and 
bisexual men may have been more likely to know about the 
HIV Futures 8 study than heterosexual men. Both the AHOD 
and HIV Futures 8 samples had similar figures with respect 
to ART use (97 and 96%, respectively). By comparison, the 
Annual Surveillance Report shows an estimated 73% of people 
diagnosed with HIV using ART in 2014. Both AHOD and HIV 
Futures 8 capture data from people who are more likely to be 
connected to clinical services and so more likely to be using ART. 
Figures in the Annual Surveillance Report take into account 
people who are newly diagnosed with HIV who may not yet 
have commenced ART or be established in clinical care. Among 
HIV Futures 8 participants, people who had been living with 
HIV for 5  years or less were significantly less likely to be on 
ART than those who had been living with HIV for 6 years or 
more, χ2 (1, N = 857) = 16.11, p < 0.001.
DIscUssIoN
HIV Futures is the largest and longest-running study of the 
health and well-being of Australians living with HIV. This is 
the major strength of this study. It is a unique dataset that 
collects information on a comprehensive array of demographic 
attributes, social circumstances, life experiences, and health-
related issues among people living with HIV. These data can 
be used to build a nuanced understanding of the complexity of 
factors that support a good quality of life among people living 
with HIV. The study is based on recognition that living with 
HIV can have a significant impact on an individuals’ well-being 
even when their physical health is well supported by ready 
access to ART and quality clinical care. These data contribute to 
a growing body of international data on the health, well-being, 
and quality of life of people living with HIV—including the 
relationship between quality of life and the clinical manage-
ment of HIV in Western countries. For example, data from 
HIV Futures 8 include measures that can be used to explore 
similar themes to those that have been a focus of analyses of 
the UK-based “Antiretroviral, Sexual Transmission Risk and 
Attitudes” dataset (71–74).
The socio-demographic characteristics of the HIV Futures 
8 sample broadly match that of the Australian population 
of people living with HIV based on a comparison with other 
national datasets. The validity of self-select samples in epide-
miological and health-based research is subject to debate (75). 
When studies are advertised widely through channels such as 
social media, and participants opt into the study, it is impos-
sible to determine a response rate or compare responders with 
non-responders to assess representativeness of the sample (75). 
However, there are some noted strengths of self-select samples 
recruited online, such as a greater capacity to attract “invisible” 
or hard-to-reach populations (76, 77). Some studies indicate 
that creative approaches to recruitment via social media can 
achieve representative samples of particular groups (77). 
A lack of comparable, population-wide datasets makes it dif-
ficult to know whether participants in the HIV Futures 8 survey 
are representative of the population of Australians living with 
HIV. Comparisons with the Annual Surveillance Report and 
the AHOD data suggest that people from non-English-speaking 
migrant communities are under represented in this survey, which 
we will discuss further in the limitations section below. The HIV 
Futures 8 sample is also likely to include a higher proportion 
of people currently using ART than the overall population of 
people living with HIV in Australia, because HIV Futures 8 is 
advertised through HIV clinical and support services. People 
9Power et al. HIV Futures 8: Cross-sectional and Longitudinal Protocol
Frontiers in Public Health | www.frontiersin.org March 2017 | Volume 5 | Article 50
who are yet to be engaged with treatment and care are less likely 
to have been exposed to advertising about the study.
The HIV Futures 8 sample size of 895 was slightly smaller 
than has been achieved for previous HIV Futures surveys. Both 
HIV Futures 6 in 2008 and HIV Futures 7 in 2012 had a sample 
of over 1,000 participants (22, 65). Recruitment for HIV Futures 
8 was largely centered on social media and online advertising. 
While this was effective in promoting the study, HIV Futures 8 
was competing for attention with other online surveys target-
ing people living with HIV that were recruiting at the same 
time—multiple surveys being, in part, a function of the cost-
effectiveness and ease of conducting online surveys. This may 
have created a sense of “survey fatigue” among people living with 
HIV. It is also possible that being HIV positive is less central to 
people’s lives than it was 10 or 15  years ago due to improved 
treatment and physical well-being. For this reason, people may 
feel less compelled to take part in HIV-related well-being studies 
than they were in the past.
Engagement with the HIV community sector was central 
to successful recruitment in this study. Extensive consultation 
with individuals working in the HIV sector was undertaken to 
ensure the design and content of HIV Futures 8 was relevant 
and useful for services providers and community agencies. 
This ensured the study had endorsement and support from 
the community sector. As well as being ethically appropriate, 
this facilitated recruitment as HIV community organizations 
were able to promote the study to their members—a strategy 
that was highly effective.
limitations
There are some limitations to this study that should be noted. 
The survey instrument for HIV Futures 8 was long and required 
a reasonably high level of English literacy to complete. This 
meant it would have been difficult for some people to complete 
the survey without assistance from a translator or support 
person. As a way to make the survey more accessible for 
people with lower English and/or literacy skills, we simplified 
the language in the opening section of the survey instrument 
(Part 1) as much as possible, while still ensuring it included 
core questions about health and well-being. We informed 
participants that it would be adequate for them to complete only 
Part 1 of the survey if it was challenging for them to continue. 
The Flesch Reading Score for Part 1 was 74%, indicating it 
should be readable for people with approximately seventh 
grade English literacy skills. In the Flesch system, a score of 
90–100 is considered approximately fifth grade reading level, 
while a score of 0–30 indicates college or university graduate 
reading level. Limited resources meant we did not have capacity 
to undertake the more intensive recruitment that would be 
required to engage properly with many non-English-speaking 
migrant populations in Australia. In many migrant communi-
ties in Western countries, including Australia, HIV is very a 
hidden issue and there are high levels of stigma (78, 79). The 
process of building trust and rapport with community leaders 
and community members at a level necessary to encourage 
participation in a study related to HIV would be intensive and 
take an extended period of time. We acknowledge that this is 
important work, however, that we will endeavor to develop in 
an alternative project in this area.
A limitation of the sampling method is that it relied heavily on 
advertising through social and support organizations for people 
living with HIV. While we made efforts to promote the survey 
through broader channels, particularly social media, people not 
connected to such organizations may have been less likely to 
be aware of the study has potential to introduce some sampling 
bias. Furthermore, while social media advertising may have been 
effective in targeting people less connected with the HIV service 
sector, those who are isolated from both services and social 
media channels (particularly those relating to HIV and/or LGBT 
communities) may have been less likely to be exposed to survey 
advertising.
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